GRAPHITE BIO INC's ticker is GRPH and the CUSIP is 38870X104. A total of 62 filers reported holding GRAPHITE BIO INC in Q2 2022. The put-call ratio across all filers is 1.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $71,632 | -32.0% | 28,884 | -28.7% | 0.01% | -28.6% |
Q2 2023 | $105,399 | +34.0% | 40,538 | +26.3% | 0.01% | +40.0% |
Q1 2023 | $78,643 | -30.7% | 32,099 | -6.1% | 0.01% | -16.7% |
Q4 2022 | $113,541 | +9.2% | 34,199 | +4.0% | 0.01% | +50.0% |
Q3 2022 | $104,000 | +55.2% | 32,899 | +34.5% | 0.00% | +100.0% |
Q2 2022 | $67,000 | – | 24,457 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 8,459,314 | $20,979,099 | 6.42% |
OUP Management Co., LLC | 406,308 | $1,007,644 | 2.27% |
Prosight Management, LP | 1,337,826 | $3,317,808 | 1.05% |
EcoR1 Capital, LLC | 8,538,446 | $21,175,346 | 0.71% |
TANG CAPITAL MANAGEMENT LLC | 2,016,626 | $5,001,232 | 0.71% |
Privium Fund Management (UK) Ltd | 191,244 | $453,248 | 0.36% |
Newtyn Management, LLC | 542,637 | $1,345,740 | 0.33% |
Aldebaran Capital, LLC | 130,000 | $322,400 | 0.33% |
Acuitas Investments, LLC | 195,762 | $485,490 | 0.28% |
CHI Advisors LLC | 230,938 | $572,726 | 0.23% |